(Q45215706)

10 December 2017

title

Contrasting systemic stabilities of the acyl and phenolic glucuronides of diflunisal in the rat (English)

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

12 December 2022

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

12 December 2022

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

12 December 2022

author name string

J. A. Watt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1862662

12 December 2022

A. R. King

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1862662

12 December 2022

R. G. Dickinson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1862662

12 December 2022

language of work or name

English

0 references

publication date

1 March 1991

1 reference

full work available at URL

10 December 2017

http://www.tandfonline.com/doi/pdf/10.3109/00498259109039480

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

12 December 2022

1 reference

10 December 2017

volume

21

1 reference

10 December 2017

issue

3

1 reference

10 December 2017

page(s)

403-415

1 reference

Rearrangement of valproate glucuronide in a patient with drug-associated hepatobiliary and renal dysfunction

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00498259109039480

Decreased clearance of diflunisal in renal insufficiency--an alternative explanation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498259109039480

Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498259109039480

Decreased body clearance of diflunisal in renal insufficiency-an alternative explanation [letter]

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498259109039480

Effect of dose on the glucuronidation and sulphation kinetics of diflunisal in man: single dose studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498259109039480

The formation of beta-glucuronidase resistant glucuronides by the intramolecular rearrangement of glucuronic acid conjugates at mild alkaline pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498259109039480

Irreversible binding of zomepirac to plasma protein in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498259109039480

Biliary excretion of diflunisal conjugates in patients with T-tube drainage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498259109039480

Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498259109039480

The effect of diethyl ether, pentobarbitone and urethane anaesthesia on diflunisal conjugation and disposition in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498259109039480

Reactivity considerations in the analysis of glucuronide and sulfate conjugates of diflunisal

21 January 2018

3

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

Journal of Pharmacology and Experimental Therapeutics

12 December 2022

4

221

583

Dickinson R. G.

1979

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

12 December 2022

5

12

247

Dickinson R. G.

1984

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

12 December 2022

7

14

255

Dickinson R. G.

1986

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

Elimination of diflunisal as its acyl glucuronide, phenolic glucuronide and sulfate conjugates in bile-exteriorized and intact rats

12 December 2022

8

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

Reversed-phase high-performance liquid chromatographic assay for the simultaneous determination of diflunisal and its glucuronides in serum and urine. Rearrangement of the 1-O-acylglucuronide

12 December 2022

11

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

Isolation and identification of the rearrangement products of diflunisal 1-O-acyl glucuronide

12 December 2022

12

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

12 December 2022

13

16

322

Hyneck M. L.

1988

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

Journal of Pharmacology and Experimental Therapeutics

12 December 2022

15

235

402

Lin J. H.

1985

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

12 December 2022

16

13

321

Lin J. H.

1985

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

Journal of Pharmacology and Experimental Therapeutics

12 December 2022

17

238

978

Lin J. H.

1986

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

12 December 2022

19

14

127

Loewen G. R.

1986

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

Research Communications in Chemical Pathology and Pharmacology

12 December 2022

20

66

339

McKinnon G. E.

1989

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

Journal of Pharmacology and Experimental Therapeutics

12 December 2022

21

227

732

Meffin P. J.

1983

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

Assay methodology for quantification of the ester and ether glucuronide conjugates of diflunisal in human urine

12 December 2022

22

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

Journal of Pharmacology and Experimental Therapeutics

12 December 2022

23

230

237

Rowe B. J.

1984

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

Reactions of oxaprozin-1-O-acyl glucuronide in solutions of human plasma and albumin

12 December 2022

24

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

Journal of Pharmacology and Experimental Therapeutics

12 December 2022

25

251

288

Sallustio B. C.

1989

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

12 December 2022

27

13

110

Smith P. C.

1985

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

12 December 2022

29

3

453

Tocco D. J.

1975

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

12 December 2022

30

13

318

Van Breemen R. B.

1985

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

Reactivity of diflunisal acyl glucuronide in human and rat plasma and albumin solutions

12 December 2022

34

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

Effects of blockage of urine and/or bile flow on diflunisal conjugation and disposition in rats

12 December 2022

35

1 reference

https://api.crossref.org/works/10.3109/00498259109039480

12 December 2022

Identifiers

1 reference

10 December 2017

1 reference